Liver Transplant Program News

A recent study led by Principal Investigator Michael Goran, PhD, and Rachel Schenker, MD, a Fellow in the CHLA Liver Transplant Program, has found a novel combination of plasma-based biomarkers that

Diagnosed with liver disease at 2 months of age, Mia and her family turned to CHLA’s world-class pediatric Liver Transplant Program to save her life.

CHLA-led study shows reducing disparities in assigning livers for transplant improved outcomes for patients with pediatric acute liver failure.

Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first

CHLA researchers use imaging mass cytometry analysis of biopsies to find potential biomarkers that can predict transplant rejection.

Children’s Hospital Los Angeles research study uncovers socioeconomic factors that can impact outcomes of patients with pediatric acute liver failure (PALF).

Diagnosed with hepatoblastoma at 17 months old, Aaroh is thriving thanks to chemotherapy and a liver transplant—and the experts at Children’s Hospital Los Angeles who gave him life.

Study finds that T-cells expressing PD-1 may help predict recovery in children with acute liver failure.

Living donation and significantly lower wait times helped the program to perform 35 liver transplants in 2022.